LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Chon Founds One Firm, Buys Another
Company News

Chon Founds One Firm, Buys Another

February 12, 2016 1 min read Premium comments

Advertisement

Chon Founds One Firm, Buys Another
Courtesy of CTL Medical
Secondary

CTL Medical Corporation, a Dallas, Texas-based medical device manufacturing and service company, has signed an agreement to acquire AccelSPINE, a medical device designer and manufacturer headquartered in Dallas. The acquisition went into effect January 25, 2016. Daniel Chon founded both of them.

AccelSPINE is a privately held company that was established in October 2010 by then President and CEO Chon. The company chose its Dallas headquarters in March 2011 to leverage strategic business initiatives and, according to company officials, has since experienced significant growth.

In 2015, AccelSPINE received its CE Marking and EN ISO 13485 certification. This certification allowed AccelSPINE to expand its customer base to the 28 countries that make up the European Union and 5 additional countries that adhere to European Union regulations.

“AccelSPINE is a leader in our industry, and it has a proven track record of producing exceptional medical products. Acquiring AccelSPINE not only helps advance our global growth strategy, but it also helps us meet the needs of our growing customer base, ” said CTL Medical Chief Business Development Officer Andy Choi.

The CTL Medical Corporation plans to retain all of AccelSPINE’s current employees and executives, and anticipates a significant increase in its workforce by early 2017.

Chon founded CTL Medical Corporation in 2015. His vision was to create a fully integrated, industry leading, global medical device design, development and manufacturing company.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy